Abstract:A total of 60 breast cancer (BC) tissues and adjacent healthy tissues from patients who underwent surgery in Renmin Hospital of Wuhan University were collected for analysis in the present study. Results from reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) demonstrated that, compared with the adjacent healthy tissues, the expression levels of microRNA (miR)‑142‑5p were significantly elevated in BC tissues. Bioinformatics analysis was performed using TargetScan for the prediction of potential target sites that matched the seed region of miR‑142‑5p; phosphatase and tensin homolog (PTEN) exhibited the highest score and was selected for further analysis. Results of RT‑qPCR analysis demonstrated that, compared with the adjacent healthy tissues, the mRNA expression levels of PTEN were significantly decreased in breast cancer tissues. miR‑142‑5p and PTEN expression levels were positively and negatively associated, respectively, with patient tumor size and metastasis. MDA‑MB‑231 cells were divided into three groups including the Control group, the miR‑NC inhibitor group and the miR‑142‑5p inhibitor group. As for alterations in cell behavior, including cell viability and cell apoptosis, and protein expression levels, there were no significant differences between Control and miR‑NC inhibitor groups. MTT assay results revealed that, compared with Control and miR‑NC inhibitor groups, miR‑142‑5p inhibitor reduced MDA‑MB‑231 cell proliferation. Flow cytometric analysis demonstrated that, compared with Control and miR‑NC inhibitor groups, miR‑142‑5p inhibitor treatment induced MDA‑MB‑231 cell apoptosis. Western blotting results demonstrated that, compared with Control and miR‑NC inhibitor groups, miR‑142‑5p inhibitor treatment significantly increased the expression of PTEN, reduced the activation of phosphatidylinositol‑4,5‑bisphosphate 3‑kinase/RACα serine/threonine‑protein kinase signaling. Finally, PTEN was demonstrated to interact with miR‑142‑5p from the results of dual‑luciferase reporter assay in the present study. The findings of the present study suggested that miR‑142‑5p may be a potential therapeutic target for the future investigations and insights for breast cancer.

Microrna372 Promotes Breast Cancer Cell Growth And Metastasis By Targeting Lats2

MiR-101-3p Targets KPNA2 to Inhibit the Progression of Lung Squamous Cell Carcinoma Cell Lines.

MicroRNA-34a Inhibition of the TLR Signaling Pathway Via CXCL10 Suppresses Breast Cancer Cell Invasion and Migration.

Mir-135b, Upregulated in Breast Cancer, Promotes Cell Growth and Disrupts the Cell Cycle by Regulating Lats2

Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1 promotes triple-negative breast cancer development

Microrna-187 Inhibits Pten Expression And Promotes Cell Proliferation In Non-Small-Cell Lung Cancer

Mir-221/222 Promote Cancer Stem-Like Cell Properties and Tumor Growth of Breast Cancer Via Targeting PTEN and Sustained Akt/NF-κB/COX-2 Activation.

Microrna-34a Suppresses Cell Proliferation by Targeting Lmtk3 in Human Breast Cancer Mcf-7 Cell Line

MicroRNA-218-5p Accelerates Malignant Behaviors of Breast Cancer Through LRIG1

The Micrornas Mir-200B-3p and Mir-429-5p Target the LIMK1/CFL1 Pathway to Inhibit Growth and Motility of Breast Cancer Cells

LINC00662 enhances cell progression and stemness in breast cancer by MiR-144-3p/SOX2 axis

Mir-3646 Promotes Cell Proliferation, Migration, and Invasion Via Regulating G2/M Transition in Human Breast Cancer Cells.

Mir-4262 Promotes Proliferation and Invasion of Human Breast Cancer Cells Through Directly Targeting Klf6 and Klf15

MicroRNA‑142‑5p Modulates Breast Cancer Cell Proliferation and Apoptosis by Targeting Phosphatase and Tensin Homolog

MicroRNA-20b Promotes Cell Growth of Breast Cancer Cells Partly Via Targeting Phosphatase and Tensin Homologue (PTEN).

MicroRNA-206 Inhibits Metastasis of Triple-Negative Breast Cancer by Targeting Transmembrane 4 L6 Family Member 1.

Mir-376C-3p Modulates the Properties of Breast Cancer Stem Cells by Targeting RAB2A.

MicroRNA-15a Induces Cell Apoptosis and Inhibits Metastasis by Targeting BCL2L2 in Non-Small Cell Lung Cancer

Lnc NR2F1-AS1 Promotes Breast Cancer Metastasis by Targeting the MiR-25-3p/ZEB2 Axis.

LINC01234 promoted malignant behaviors of breast cancer cells via hsa-miR-30c-2-3p/CCT4/mTOR signaling pathway

MicroRNA-1236-3p Inhibits Proliferation and Invasion of Breast Cancer Cells by Targeting ZEB1